Kazora Tablet 2mg (Doxazosin Mesylate)

Adult dosage

Hypertension: The initial dose of doxazosin mesylate is 1㎎ orally once daily. Depending on the patient's response, increase the dose to 2㎎ after 1 week. The dose may be increased gradually at 1-2-week intervals to 4㎎, 8㎎, and 16㎎ per day to achieve the desired blood pressure. If blood pressure is not adequately controlled with this medicine alone, it may be administered with a thiazide diuretic or β-blocker. Urinary retention and voiding disorders due to benign prostatic hyperplasia: The initial dose is 1㎎ once daily. Depending on the patient's blood pressure, the daily dose may be increased to 2㎎ at 1-2-week intervals, and then gradually increased to 4㎎ and up to 8㎎. Adjust the dose appropriately according to age and symptoms.

This medication may cause orthostatic hypotension, which can lead to dizziness or fainting symptoms when starting treatment or increasing the dosage. Therefore, it is important to start with a lower dose and gradually increase it. This drug can cause persistent penile erections, so if this occurs, prompt treatment is required to prevent permanent erectile dysfunction. Patients with allergies to this drug or similar medications, leukopenia, hypotension, or certain genetic lactose intolerance should not take this medication. Patients with impaired liver function must exercise particular caution when using this drug. Regular testing is needed during treatment due to a potential decrease in blood cell counts, and patients should consult healthcare providers immediately if adverse symptoms arise. Various side effects such as dizziness, headache, drowsiness, anxiety, nausea, palpitations may occur, and if symptoms worsen, patients should inform their doctor. Caution is required during treatment; rise slowly when getting up, and if hypotension symptoms occur, lie down or take rest. This drug may increase the risk of hypotension if taken with other antihypertensive drugs or specific erectile dysfunction treatments, so it must be discussed with healthcare providers. Women who are pregnant or breastfeeding should consult their doctor before taking this medication, and it is advisable to avoid administration while breastfeeding. The safety of this medication in children and the elderly has not been fully established; special caution is needed when administering it to them. In case of overdose, lie down immediately and seek necessary treatment, as this drug cannot be removed by dialysis and medical intervention is essential. Medications should be stored out of reach of children, and it is safe not to change containers.

• Syncope
• dizziness
• agranulocytosis
• leukopenia
• neutropenia
• thrombocytopenia
• headache
• drowsiness
• anxiety
• insomnia

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance

White rectangular tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle, For export - 10 tablets/blister